IDEAS home Printed from https://ideas.repec.org/f/pda291.html
   My authors  Follow this author

Patricia M. Danzon

Personal Details

First Name:Patricia
Middle Name:M.
Last Name:Danzon
Suffix:
RePEc Short-ID:pda291
[This author has chosen not to make the email address public]
https://hcmg.wharton.upenn.edu/profile/danzon/

Affiliation

Wharton School of Business
University of Pennsylvania

Philadelphia, Pennsylvania (United States)
http://www.wharton.upenn.edu/
RePEc:edi:wsupaus (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters Books

Working papers

  1. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
  2. Patricia M. Danzon & Nuno S. Pereira, 2011. "Vaccine Supply: Effects Of Regulation And Competition," NBER Working Papers 17205, National Bureau of Economic Research, Inc.
  3. Patricia Danzon;Martina Garau;Adrian Towse, 2011. "Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?," Occasional Paper 000191, Office of Health Economics.
  4. Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2011. "Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement," NBER Working Papers 17174, National Bureau of Economic Research, Inc.
  5. Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
  6. Patricia M. Danzon & Andrew J. Epstein, 2008. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," NBER Working Papers 14041, National Bureau of Economic Research, Inc.
  7. Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2004. "Mergers and Acquisitions in the Pharmaceutical and Biotech Industries," NBER Working Papers 10536, National Bureau of Economic Research, Inc.
  8. Patricia M. Danzon & Y. Richard Wang & Liang Wang, 2003. "The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s," NBER Working Papers 9874, National Bureau of Economic Research, Inc.
  9. Patricia M. Danzon & Jonathan D. Ketcham, 2003. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand," NBER Working Papers 10007, National Bureau of Economic Research, Inc.
  10. Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira, 2003. "Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances," NBER Working Papers 9615, National Bureau of Economic Research, Inc.
  11. Sean Nicholson & Patricia M. Danzon & Jeffrey S. McCullough, 2002. "Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality," NBER Working Papers 9007, National Bureau of Economic Research, Inc.
  12. Patricia M. Danzon & Stephen B. Soumerai, 2002. "Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy," Center for Policy Research Reports 23, Center for Policy Research, Maxwell School, Syracuse University.
  13. Danzon, Patricia M. & Pauly, Mark V. & Kington, Raynard S., 1990. "The Effects of Malpractice Litigation on Physicians' Fees and Incomes," Working Papers 59, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  14. Danzon, Patricia M. & Pauly, Mark V. & Kington, Raynard S., 1990. "The Effects of Malpractice Litigation on Physicians' Fees and Incomes," Working Papers 59, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  15. Danzon, Patricia M., 1990. "Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects," Working Papers 60, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
    repec:max:cprpbr:23 is not listed on IDEAS
    repec:fth:chices:60 is not listed on IDEAS

Articles

  1. Patricia M. Danzon, 2018. "Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues," PharmacoEconomics, Springer, vol. 36(12), pages 1395-1405, December.
  2. Patricia M. Danzon, 2015. "Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 245-261, July.
  3. Patricia Danzon & Adrian Towse & Jorge Mestre‐Ferrandiz, 2015. "Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 294-301, March.
  4. Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2015. "Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement," Health Economics, John Wiley & Sons, Ltd., vol. 24(2), pages 238-252, February.
  5. Patricia Danzon & Nuno Sousa Pereira, 2011. "Vaccine Supply: Effects of Regulation and Competition," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 18(2), pages 239-271.
  6. Harrington, Scott E. & Danzon, Patricia M. & Epstein, Andrew J., 2008. ""Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market," Journal of Banking & Finance, Elsevier, vol. 32(1), pages 157-169, January.
  7. Ernst R. Berndt & Patricia M. Danzon & Gregory B. Kruse, 2007. "Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 231-250.
  8. Patricia M. Danzon, 2007. "At what price?," Nature, Nature, vol. 449(7159), pages 176-179, September.
  9. Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2007. "Mergers and acquisitions in the pharmaceutical and biotech industries," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 307-328.
  10. Danzon, Patricia M. & Nicholson, Sean & Pereira, Nuno Sousa, 2005. "Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances," Journal of Health Economics, Elsevier, vol. 24(2), pages 317-339, March.
  11. Patricia M. Danzon & Y. Richard Wang & Liang Wang, 2005. "The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s," Health Economics, John Wiley & Sons, Ltd., vol. 14(3), pages 269-292, March.
  12. Danzon Patricia M. & Ketcham Jonathan D., 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-56, January.
  13. Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger, 2002. "A general model of the impact of absenteeism on employers and employees," Health Economics, John Wiley & Sons, Ltd., vol. 11(3), pages 221-231, April.
  14. Patricia M. Danzon & Mark V. Pauly, 2002. "Health Insurance and the Growth in Pharmaceutical Expenditures," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 587-613.
  15. Danzon, Patricia M., 2002. "Welfare effects of supplementary insurance: a comment," Journal of Health Economics, Elsevier, vol. 21(5), pages 923-926, September.
  16. Danzon, Patricia & Sloan, Frank, 2001. "Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions."," The Journal of Legal Studies, University of Chicago Press, vol. 30(2), pages 661-668, June.
  17. Danzon, Patricia M & Harrington, Scott E, 2001. "Worker's Compensation Rate Regulation: How Price Controls Increase Costs," Journal of Law and Economics, University of Chicago Press, vol. 44(1), pages 1-36, April.
  18. Danzon, Patricia M. & Chao, Li-Wei, 2000. "Cross-national price differences for pharmaceuticals: how large, and why?," Journal of Health Economics, Elsevier, vol. 19(2), pages 159-195, March.
  19. Danzon, Patricia M & Chao, Li-Wei, 2000. "Does Regulation Drive out Competition in Pharmaceutical Markets?," Journal of Law and Economics, University of Chicago Press, vol. 43(2), pages 311-357, October.
  20. Harrington, Scott E & Danzon, Patricia M, 2000. "Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance," The Journal of Business, University of Chicago Press, vol. 73(4), pages 569-595, October.
  21. Adrian Towse & Patricia Danzon, 1999. "Medical negligence and the NHS: an economic analysis," Health Economics, John Wiley & Sons, Ltd., vol. 8(2), pages 93-101, March.
  22. Danzon, Patricia M, 1997. "Tort Liability: A Minefield for Managed Care?," The Journal of Legal Studies, University of Chicago Press, vol. 26(2), pages 491-519, June.
  23. Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 301-322.
  24. Cummins, J. David & Danzon, Patricia M., 1997. "Price, Financial Quality, and Capital Flows in Insurance Markets," Journal of Financial Intermediation, Elsevier, vol. 6(1), pages 3-38, January.
  25. Patricia M. Danzon, 1995. "A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 14(4), pages 636-638.
  26. Patricia M. Danzon & Grant D. H. Maclaine, 1994. "Health Care Reform," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 27(2), pages 81-88, April.
  27. Harrington, Scott E & Danzon, Patricia M, 1994. "Price Cutting in Liability Insurance Markets," The Journal of Business, University of Chicago Press, vol. 67(4), pages 511-538, October.
  28. Danzon, Patrigia M., 1994. "The Swedish patient compensation system: Myths and realities," International Review of Law and Economics, Elsevier, vol. 14(4), pages 453-466, December.
  29. Danzon, Patricia M, 1994. "Tort Reform: The Case of Medical Malpractice," Oxford Review of Economic Policy, Oxford University Press and Oxford Review of Economic Policy Limited, vol. 10(1), pages 84-98, Spring.
  30. Danzon, Patricia, 1993. "Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment," Journal of Law and Economics, University of Chicago Press, vol. 36(1), pages 587-594, April.
  31. Danzon, Patricia M, 1993. "The Economic Implications of Public Disability Insurance in the United States," Journal of Labor Economics, University of Chicago Press, vol. 11(1), pages 170-200, January.
  32. Patricia M. Danzon, 1991. "Liability for Medical Malpractice," Journal of Economic Perspectives, American Economic Association, vol. 5(3), pages 51-69, Summer.
  33. Patricia M Danzon, 1990. "Alternative Liability Regimes for Medical Injuries," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 15(1), pages 3-21, January.
  34. Danzon, Patricia M & Pauly, Mark V & Kington, Raynard S, 1990. "The Effects of Malpractice Litigation on Physicians' Fees and Incomes," American Economic Review, American Economic Association, vol. 80(2), pages 122-127, May.
  35. Danzon, Patricia M, 1988. "The Political Economy of Workers' Compensation: Lessons for Product Liability," American Economic Review, American Economic Association, vol. 78(2), pages 305-310, May.
  36. Danzon, Patricia M., 1985. "Liability and liability insurance for medical malpractice," Journal of Health Economics, Elsevier, vol. 4(4), pages 309-331, December.
  37. Danzon, Patricia, 1984. "The Frequency and Severity of Medical Malpractice Claims," Journal of Law and Economics, University of Chicago Press, vol. 27(1), pages 115-148, April.
  38. Flowers, Marilyn R. & Danzon, Patricia M., 1984. "Separation of the redistributive and allocative functions of government : A public choice perspective," Journal of Public Economics, Elsevier, vol. 24(3), pages 373-380, August.
  39. Patricia Munch Danzon, 1983. "Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 3(1), pages 154-155.
  40. Patricia Munch Danzon, 1983. "Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 3(1), pages 154-154.
  41. Patricia Munch Danzon, 1983. "Contingent Fees for Personal Injury Litigation," Bell Journal of Economics, The RAND Corporation, vol. 14(1), pages 213-224, Spring.
  42. Danzon, Patricia Munch, 1982. "Hospital `profits' : The effects of reimbursement policies," Journal of Health Economics, Elsevier, vol. 1(1), pages 29-52, May.
  43. Patricia Munch Danzon, 1982. "Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 2(1), pages 141-141.

Chapters

  1. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
  2. Patricia M. Danzon, 2012. "Regulation of the Biopharmaceutical Industry," Chapters, in: Roger J. Van den Bergh & Alessio M. Pacces (ed.), Regulation and Economics, chapter 14, Edward Elgar Publishing.
  3. Patricia M. Danzon & Andrew J. Epstein, 2012. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," Advances in Health Economics and Health Services Research, in: The Economics of Medical Technology, pages 35-71, Emerald Group Publishing Limited.
  4. Patricia M. Danzon & Jonathan D. Ketcham, 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 1-54, National Bureau of Economic Research, Inc.
  5. Danzon, Patricia M., 2000. "Liability for medical malpractice," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 26, pages 1339-1404, Elsevier.
  6. Patricia M. Danzon & Allison Percy, 1999. "The Effects of Price Regulation on Productivity in Pharmaceuticals," NBER Chapters, in: International and Interarea Comparisons of Income, Output, and Prices, pages 371-418, National Bureau of Economic Research, Inc.

Books

  1. Danzon, Patricia M. & Nicholson, Sean (ed.), 2012. "The Oxford Handbook of the Economics of the Biopharmaceutical Industry," OUP Catalogue, Oxford University Press, number 9780199742998.
  2. Patricia Danzon;Jeong Kim, 2002. "The Life Cycle of Pharmaceuticals: A Cross-National Perspective," Monograph 000480, Office of Health Economics.
  3. Patricia Danzon;Li-Wei Chao, 2000. "Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison," Monograph 000462, Office of Health Economics.
  4. Patricia Danzon, 1997. "Trade and Price Differentials for Pharmaceuticals: Policy Options," Monograph 000430, Office of Health Economics.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Number of Distinct Works, Weighted by Simple Impact Factor
  2. Number of Distinct Works, Weighted by Recursive Impact Factor
  3. Number of Distinct Works, Weighted by Number of Authors and Simple Impact Factors
  4. Number of Distinct Works, Weighted by Number of Authors and Recursive Impact Factors
  5. Number of Citations, Weighted by Number of Authors and Recursive Impact Factors
  6. h-index
  7. Number of Journal Pages, Weighted by Simple Impact Factor
  8. Number of Journal Pages, Weighted by Recursive Impact Factor
  9. Number of Journal Pages, Weighted by Number of Authors
  10. Number of Journal Pages, Weighted by Number of Authors and Simple Impact Factors
  11. Number of Journal Pages, Weighted by Number of Authors and Recursive Impact Factors
  12. Wu-Index

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 8 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-COM: Industrial Competition (6) 2003-11-30 2004-06-07 2008-06-07 2011-07-13 2011-07-27 2012-12-15. Author is listed
  2. NEP-HEA: Health Economics (6) 2003-04-13 2003-07-29 2004-06-07 2008-06-07 2011-07-13 2011-07-27. Author is listed
  3. NEP-EDU: Education (2) 2003-07-29 2003-11-30
  4. NEP-HME: Heterodox Microeconomics (2) 2011-07-13 2011-07-27
  5. NEP-REG: Regulation (2) 2008-06-07 2011-07-27
  6. NEP-ACC: Accounting and Auditing (1) 2004-06-07
  7. NEP-BEC: Business Economics (1) 2011-07-27
  8. NEP-CFN: Corporate Finance (1) 2004-06-07
  9. NEP-EEC: European Economics (1) 2003-11-30
  10. NEP-ENT: Entrepreneurship (1) 2003-04-13
  11. NEP-IND: Industrial Organization (1) 2003-04-13
  12. NEP-LAW: Law and Economics (1) 2008-06-07
  13. NEP-MIC: Microeconomics (1) 2008-06-07
  14. NEP-MKT: Marketing (1) 2008-06-07

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Patricia M. Danzon should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.